John Sweetenham, MD

    John Sweetenham, MD

    Senior Director of Clinical Affairs, Executive Medical Director, Huntsman Cancer Institute, Salt Lake City, Utah

    You Make the Call

    • What options do I have for an elderly patient with Hodgkin lymphoma who cannot tolerate ABVD? Sunday, March 1st, 2015

      John Sweetenham, MDSenior Director of Clinical Affairs, Executive Medical Director, Huntsman Cancer Institute, Salt Lake City, Utah This month, John Sweetenham, MD, advises on treatment options for an elderly patient with Hodgkin lymphoma. CLINICAL DILEMMA I have a 90-year-old female patient with relatively poor performance status and newly diagnosed bulky, symptomatic Hodgkin lymphoma. What treatment options [...]

    back to top
    SHARE